VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Prod...
FDA Recall #Z-2104-2025 — Class II — June 10, 2025
Product Description
VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.
Reason for Recall
Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.
Recalling Firm
Boston Scientific Corporation — Saint Paul, MN
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Devices
Product Quantity
14,724
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.
Code Information
UDI-DI 00685447006121 Lot 35935598
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medical device immediately and consult your healthcare provider. Contact the recalling firm for instructions on return or replacement. If you experienced an adverse event, inform your doctor.